Targeted Sequencing And Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Sequencing, Re-sequencing( Electrophoresis-based resequencing, NGS, Array-based resequencing)), By Type (DNA-based targeted sequencing, RNA-based targeted sequencing), By Application (Clinical application, Plant and animal sciences, Drug development, Others), By End use (Hospitals & clinics, Academic research, Others), By Region and Competition, 2019-2029F
Global Targeted Sequencing And Resequencing Market was valued at USD 5.11 Billion in 2023 and is anticipated t%li%project steady growth in the forecast period with a CAGR of 5.25% through 2029. Targeted sequencing and resequencing have emerged as essential tools in genomics research, enabling scientists t%li%delve deeper int%li%the intricacies of genetic variations with unprecedented precision. These techniques hold immense promise in elucidating disease mechanisms, identifying therapeutic targets, and facilitating personalized medicine approaches. As the demand for genomic insights continues t%li%grow, the global targeted sequencing and resequencing market witnessed significant expansion, driven by technological advancements and increasing applications across diverse sectors.
The global targeted sequencing and resequencing market has experienced robust growth in recent years, propelled by the burgeoning adoption of next-generation sequencing (NGS) technologies and a rising emphasis on personalized healthcare solutions. Targeted sequencing involves selectively sequencing specific regions of interest within the genome, offering enhanced efficiency and cost-effectiveness compared t%li%whole-genome sequencing. On the other hand, resequencing involves the comparison of an individual's genome t%li%a reference genome, facilitating the detection of genetic variations associated with diseases or traits.
Key Market Drivers
Rising Investments in Precision Medicine is Driving the Global Targeted Sequencing And Resequencing Market
Precision medicine, a groundbreaking approach that tailors medical treatment t%li%individual characteristics, is revolutionizing healthcare. At the forefront of this revolution is targeted sequencing and resequencing, technologies that allow for the precise analysis of genetic information. As investments in precision medicine soar, the global targeted sequencing and resequencing market is experiencing unprecedented growth. Precision medicine represents a paradigm shift in healthcare, moving away from the traditional one-size-fits-all approach t%li%treatments and diagnostics. By leveraging advances in genomics, proteomics, and other omics technologies, precision medicine seeks t%li%understand the unique genetic makeup of each patient and tailor medical interventions accordingly. This personalized approach holds the promise of more effective treatments with fewer side effects, ultimately improving patient outcomes.
At the heart of precision medicine lies the ability t%li%accurately sequence and analyze the genome. Targeted sequencing and resequencing are powerful techniques that enable researchers and clinicians t%li%examine specific regions of the genome with unparalleled precision. Targeted sequencing focuses on sequencing predetermined regions of interest, such as genes associated with specific diseases or drug responses. Resequencing, on the other hand, involves comparing an individual's genome t%li%a reference genome t%li%identify variations or mutations.
Growing Demand for Research Tools and Services is Driving the Global Targeted Sequencing And Resequencing Market
Genomic research has become integral t%li%various scientific disciplines, including healthcare, agriculture, forensics, and evolutionary biology. The ability t%li%sequence and analyze specific regions of the genome with high accuracy and efficiency has revolutionized our understanding of genetic variations, disease mechanisms, and evolutionary relationships. Targeted sequencing and resequencing techniques, such as polymerase chain reaction (PCR) amplification, hybridization capture, and amplicon sequencing, have significantly contributed t%li%advancing genomic studies by allowing researchers t%li%focus on specific regions of interest.
With the growing emphasis on personalized medicine, there is an increasing need t%li%identify genetic variants associated with diseases, drug responses, and treatment outcomes. Targeted sequencing facilitates the identification of relevant genetic markers with high specificity and sensitivity, paving the way for tailored therapeutic interventions. Cancer is a genetically heterogeneous disease characterized by complex molecular alterations. Targeted sequencing enables comprehensive profiling of cancer genomes, leading t%li%the discovery of driver mutations, assessment of tumor heterogeneity, and identification of potential therapeutic targets. As precision oncology gains traction, the demand for targeted sequencing in cancer research and clinical diagnostics continues t%li%rise.
In agriculture, targeted sequencing plays a crucial role in crop improvement, livestock breeding, and biodiversity conservation. By analyzing specific genomic regions associated with desirable traits such as yield, disease resistance, and nutritional content, researchers can accelerate the development of genetically superior crops and livestock breeds, contributing t%li%global food security and sustainability. Rapid and accurate detection of pathogens is essential for disease surveillance, outbreak investigation, and public health response. Targeted sequencing enables the selective amplification and sequencing of microbial genomes, facilitating the identification and characterization of infectious agents, including bacteria, viruses, and parasites. This capability is particularly valuable in monitoring emerging infectious diseases and tracking transmission dynamics.
Key Market Challenges
Data Analysis and Interpretation
Another significant hurdle in the global targeted sequencing and resequencing market is the complexity of data analysis and interpretation. The massive amount of sequencing data generated from these techniques requires sophisticated bioinformatics tools and expertise t%li%extract meaningful insights. Analyzing sequencing data involves various steps, including read alignment, variant calling, and annotation, each of which presents its own set of challenges.
T%li%address this issue, there is a growing demand for user-friendly bioinformatics software that can streamline data analysis workflows and provide actionable results. Additionally, there is a need for specialized training programs and workshops t%li%educate researchers and clinicians on best practices for data analysis and interpretation.
Standardization and Quality Control
Ensuring the accuracy and reproducibility of sequencing results is crucial for the success of targeted sequencing and resequencing applications, particularly in clinical settings where decisions regarding patient care may be based on sequencing data. However, achieving consistent results across different sequencing platforms and laboratories remains a significant challenge due t%li%the lack of standardized protocols and quality control measures.
Industry organizations and regulatory agencies play a vital role in addressing this challenge by developing guidelines and standards for sample preparation, sequencing protocols, and data analysis pipelines. Additionally, the implementation of rigorous quality control measures, such as regular performance monitoring and proficiency testing, can help ensure the reliability of sequencing results.
Key Market Trends
Technological Advancements
In recent years, the field of genomics has witnessed a rapid evolution, driven largely by advancements in sequencing technologies. One of the most significant developments in this realm is targeted sequencing and resequencing, which allows researchers t%li%focus on specific regions of the genome with high precision and accuracy. This technology has revolutionized various aspects of genetic research, including disease diagnosis, drug discovery, and personalized medicine. As a result, the global targeted sequencing and resequencing market is experiencing substantial growth, propelled by the increasing demand for efficient and cost-effective genomic analysis tools.
Targeted sequencing involves the selective amplification and sequencing of specific regions of interest within the genome. This approach offers several advantages over whole-genome sequencing, including reduced costs, faster turnaround times, and higher sequencing depth, leading t%li%greater sensitivity for detecting genetic variations. By targeting only relevant genomic regions, researchers can efficiently interrogate specific genes or genomic regions associated with particular diseases or traits.
Resequencing, on the other hand, involves the comparison of an individual's genome t%li%a reference genome t%li%identify genetic variations, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variants. This enables researchers t%li%study genetic diversity within populations, identify disease-causing mutations, and understand the genetic basis of complex traits.
The growing adoption of targeted sequencing and resequencing technologies can be attributed t%li%several factors. Firstly, advancements in sequencing platforms, such as next-generation sequencing (NGS) and third-generation sequencing technologies, have significantly enhanced the speed, accuracy, and cost-effectiveness of genomic analysis. These platforms offer higher throughput, increased read lengths, and improved sequencing chemistry, allowing researchers t%li%generate large volumes of sequencing data with unprecedented accuracy and resolution.
Furthermore, the development of innovative library preparation methods, sequencing chemistries, and bioinformatics tools has further streamlined the targeted sequencing and resequencing workflow, making it more accessible t%li%researchers with diverse backgrounds and expertise. Additionally, collaborations between academia, industry, and government agencies have facilitated the translation of genomic research findings int%li%clinical applications, driving the adoption of targeted sequencing and resequencing in healthcare settings.
The applications of targeted sequencing and resequencing are vast and encompass various fields, including medical genetics, oncology, agriculture, and forensics. In medical genetics, targeted sequencing is used for the diagnosis of inherited diseases, pharmacogenomics, and prenatal screening. In oncology, targeted sequencing plays a crucial role in identifying somatic mutations associated with cancer development, predicting treatment response, and monitoring disease progression. In agriculture, targeted sequencing is utilized for crop improvement, trait mapping, and biodiversity conservation. In forensics, targeted sequencing is employed for human identification, paternity testing, and forensic DNA analysis.
Segmental Insights
Technology Insights
Based on the category of technology, Sequencing emerged as the dominant segment in the global market for Targeted Sequencing And Resequencing in 2023. Sequencing technologies have experienced a rapid evolution, characterized by increased throughput, enhanced accuracy, and reduced costs. These advancements have empowered researchers with the ability t%li%efficiently analyze specific regions of the genome, facilitating targeted sequencing and resequencing endeavors. Next-generation sequencing (NGS) has emerged as a cornerstone technology in the field of genomics. Its high-throughput capabilities and cost-effectiveness have democratized genomic research, enabling widespread adoption across academic, clinical, and industrial sectors. NGS platforms such as Illumina's HiSeq, NovaSeq, and MiSeq have become synonymous with targeted sequencing applications, empowering researchers t%li%explore genetic variations with unprecedented depth and scale.
Application Insights
The Clinical application segment is projected t%li%experience rapid growth during the forecast period. Targeted sequencing enables precise analysis of specific genomic regions associated with diseases. This capability is pivotal in advancing precision medicine initiatives, where treatments are tailored t%li%individual genetic profiles. As precision medicine gains prominence, the demand for targeted sequencing in clinical settings escalates. Targeted sequencing facilitates accurate diagnosis of genetic disorders and provides insights int%li%disease risk assessment. Clinicians utilize this technology t%li%identify mutations responsible for various ailments, enabling early detection and intervention. Consequently, targeted sequencing has become integral t%li%clinical diagnostics, driving its adoption in healthcare institutions worldwide.
Regional Insights
North America emerged as the dominant region in the global Targeted Sequencing And Resequencing market in 2023, holding the largest market share in terms of value. North America, particularly the United States and Canada, boasts a robust ecosystem of biotechnology companies, research institutions, and academic centers focused on genomics. These entities have invested heavily in cutting-edge technologies for targeted sequencing and resequencing, driving innovation and market growth. With ample funding and resources, North American companies and research organizations lead the way in developing advanced sequencing platforms, bioinformatics tools, and applications for genomic analysis.
Key Market Players
In this report, the Global Targeted Sequencing And Resequencing Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Targeted Sequencing And Resequencing Market.
Available Customizations:
Global Targeted Sequencing And Resequencing market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
The global targeted sequencing and resequencing market has experienced robust growth in recent years, propelled by the burgeoning adoption of next-generation sequencing (NGS) technologies and a rising emphasis on personalized healthcare solutions. Targeted sequencing involves selectively sequencing specific regions of interest within the genome, offering enhanced efficiency and cost-effectiveness compared t%li%whole-genome sequencing. On the other hand, resequencing involves the comparison of an individual's genome t%li%a reference genome, facilitating the detection of genetic variations associated with diseases or traits.
Key Market Drivers
Rising Investments in Precision Medicine is Driving the Global Targeted Sequencing And Resequencing Market
Precision medicine, a groundbreaking approach that tailors medical treatment t%li%individual characteristics, is revolutionizing healthcare. At the forefront of this revolution is targeted sequencing and resequencing, technologies that allow for the precise analysis of genetic information. As investments in precision medicine soar, the global targeted sequencing and resequencing market is experiencing unprecedented growth. Precision medicine represents a paradigm shift in healthcare, moving away from the traditional one-size-fits-all approach t%li%treatments and diagnostics. By leveraging advances in genomics, proteomics, and other omics technologies, precision medicine seeks t%li%understand the unique genetic makeup of each patient and tailor medical interventions accordingly. This personalized approach holds the promise of more effective treatments with fewer side effects, ultimately improving patient outcomes.
At the heart of precision medicine lies the ability t%li%accurately sequence and analyze the genome. Targeted sequencing and resequencing are powerful techniques that enable researchers and clinicians t%li%examine specific regions of the genome with unparalleled precision. Targeted sequencing focuses on sequencing predetermined regions of interest, such as genes associated with specific diseases or drug responses. Resequencing, on the other hand, involves comparing an individual's genome t%li%a reference genome t%li%identify variations or mutations.
Growing Demand for Research Tools and Services is Driving the Global Targeted Sequencing And Resequencing Market
Genomic research has become integral t%li%various scientific disciplines, including healthcare, agriculture, forensics, and evolutionary biology. The ability t%li%sequence and analyze specific regions of the genome with high accuracy and efficiency has revolutionized our understanding of genetic variations, disease mechanisms, and evolutionary relationships. Targeted sequencing and resequencing techniques, such as polymerase chain reaction (PCR) amplification, hybridization capture, and amplicon sequencing, have significantly contributed t%li%advancing genomic studies by allowing researchers t%li%focus on specific regions of interest.
With the growing emphasis on personalized medicine, there is an increasing need t%li%identify genetic variants associated with diseases, drug responses, and treatment outcomes. Targeted sequencing facilitates the identification of relevant genetic markers with high specificity and sensitivity, paving the way for tailored therapeutic interventions. Cancer is a genetically heterogeneous disease characterized by complex molecular alterations. Targeted sequencing enables comprehensive profiling of cancer genomes, leading t%li%the discovery of driver mutations, assessment of tumor heterogeneity, and identification of potential therapeutic targets. As precision oncology gains traction, the demand for targeted sequencing in cancer research and clinical diagnostics continues t%li%rise.
In agriculture, targeted sequencing plays a crucial role in crop improvement, livestock breeding, and biodiversity conservation. By analyzing specific genomic regions associated with desirable traits such as yield, disease resistance, and nutritional content, researchers can accelerate the development of genetically superior crops and livestock breeds, contributing t%li%global food security and sustainability. Rapid and accurate detection of pathogens is essential for disease surveillance, outbreak investigation, and public health response. Targeted sequencing enables the selective amplification and sequencing of microbial genomes, facilitating the identification and characterization of infectious agents, including bacteria, viruses, and parasites. This capability is particularly valuable in monitoring emerging infectious diseases and tracking transmission dynamics.
Key Market Challenges
Data Analysis and Interpretation
Another significant hurdle in the global targeted sequencing and resequencing market is the complexity of data analysis and interpretation. The massive amount of sequencing data generated from these techniques requires sophisticated bioinformatics tools and expertise t%li%extract meaningful insights. Analyzing sequencing data involves various steps, including read alignment, variant calling, and annotation, each of which presents its own set of challenges.
T%li%address this issue, there is a growing demand for user-friendly bioinformatics software that can streamline data analysis workflows and provide actionable results. Additionally, there is a need for specialized training programs and workshops t%li%educate researchers and clinicians on best practices for data analysis and interpretation.
Standardization and Quality Control
Ensuring the accuracy and reproducibility of sequencing results is crucial for the success of targeted sequencing and resequencing applications, particularly in clinical settings where decisions regarding patient care may be based on sequencing data. However, achieving consistent results across different sequencing platforms and laboratories remains a significant challenge due t%li%the lack of standardized protocols and quality control measures.
Industry organizations and regulatory agencies play a vital role in addressing this challenge by developing guidelines and standards for sample preparation, sequencing protocols, and data analysis pipelines. Additionally, the implementation of rigorous quality control measures, such as regular performance monitoring and proficiency testing, can help ensure the reliability of sequencing results.
Key Market Trends
Technological Advancements
In recent years, the field of genomics has witnessed a rapid evolution, driven largely by advancements in sequencing technologies. One of the most significant developments in this realm is targeted sequencing and resequencing, which allows researchers t%li%focus on specific regions of the genome with high precision and accuracy. This technology has revolutionized various aspects of genetic research, including disease diagnosis, drug discovery, and personalized medicine. As a result, the global targeted sequencing and resequencing market is experiencing substantial growth, propelled by the increasing demand for efficient and cost-effective genomic analysis tools.
Targeted sequencing involves the selective amplification and sequencing of specific regions of interest within the genome. This approach offers several advantages over whole-genome sequencing, including reduced costs, faster turnaround times, and higher sequencing depth, leading t%li%greater sensitivity for detecting genetic variations. By targeting only relevant genomic regions, researchers can efficiently interrogate specific genes or genomic regions associated with particular diseases or traits.
Resequencing, on the other hand, involves the comparison of an individual's genome t%li%a reference genome t%li%identify genetic variations, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variants. This enables researchers t%li%study genetic diversity within populations, identify disease-causing mutations, and understand the genetic basis of complex traits.
The growing adoption of targeted sequencing and resequencing technologies can be attributed t%li%several factors. Firstly, advancements in sequencing platforms, such as next-generation sequencing (NGS) and third-generation sequencing technologies, have significantly enhanced the speed, accuracy, and cost-effectiveness of genomic analysis. These platforms offer higher throughput, increased read lengths, and improved sequencing chemistry, allowing researchers t%li%generate large volumes of sequencing data with unprecedented accuracy and resolution.
Furthermore, the development of innovative library preparation methods, sequencing chemistries, and bioinformatics tools has further streamlined the targeted sequencing and resequencing workflow, making it more accessible t%li%researchers with diverse backgrounds and expertise. Additionally, collaborations between academia, industry, and government agencies have facilitated the translation of genomic research findings int%li%clinical applications, driving the adoption of targeted sequencing and resequencing in healthcare settings.
The applications of targeted sequencing and resequencing are vast and encompass various fields, including medical genetics, oncology, agriculture, and forensics. In medical genetics, targeted sequencing is used for the diagnosis of inherited diseases, pharmacogenomics, and prenatal screening. In oncology, targeted sequencing plays a crucial role in identifying somatic mutations associated with cancer development, predicting treatment response, and monitoring disease progression. In agriculture, targeted sequencing is utilized for crop improvement, trait mapping, and biodiversity conservation. In forensics, targeted sequencing is employed for human identification, paternity testing, and forensic DNA analysis.
Segmental Insights
Technology Insights
Based on the category of technology, Sequencing emerged as the dominant segment in the global market for Targeted Sequencing And Resequencing in 2023. Sequencing technologies have experienced a rapid evolution, characterized by increased throughput, enhanced accuracy, and reduced costs. These advancements have empowered researchers with the ability t%li%efficiently analyze specific regions of the genome, facilitating targeted sequencing and resequencing endeavors. Next-generation sequencing (NGS) has emerged as a cornerstone technology in the field of genomics. Its high-throughput capabilities and cost-effectiveness have democratized genomic research, enabling widespread adoption across academic, clinical, and industrial sectors. NGS platforms such as Illumina's HiSeq, NovaSeq, and MiSeq have become synonymous with targeted sequencing applications, empowering researchers t%li%explore genetic variations with unprecedented depth and scale.
Application Insights
The Clinical application segment is projected t%li%experience rapid growth during the forecast period. Targeted sequencing enables precise analysis of specific genomic regions associated with diseases. This capability is pivotal in advancing precision medicine initiatives, where treatments are tailored t%li%individual genetic profiles. As precision medicine gains prominence, the demand for targeted sequencing in clinical settings escalates. Targeted sequencing facilitates accurate diagnosis of genetic disorders and provides insights int%li%disease risk assessment. Clinicians utilize this technology t%li%identify mutations responsible for various ailments, enabling early detection and intervention. Consequently, targeted sequencing has become integral t%li%clinical diagnostics, driving its adoption in healthcare institutions worldwide.
Regional Insights
North America emerged as the dominant region in the global Targeted Sequencing And Resequencing market in 2023, holding the largest market share in terms of value. North America, particularly the United States and Canada, boasts a robust ecosystem of biotechnology companies, research institutions, and academic centers focused on genomics. These entities have invested heavily in cutting-edge technologies for targeted sequencing and resequencing, driving innovation and market growth. With ample funding and resources, North American companies and research organizations lead the way in developing advanced sequencing platforms, bioinformatics tools, and applications for genomic analysis.
Key Market Players
- Agilent Technologies Inc.
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd
- Therm%li%Fisher Scientific, Inc.
- DNASTAR Inc.
- Bio-Rad Laboratories, Inc.
- Integrated DNA Technologies, Inc.
- Perkin Elmer, Inc.
- RainDance Technologies, Inc.
- Genomatix GmbH
- Macrogen, Inc.
- GATC Biotech Ag
In this report, the Global Targeted Sequencing And Resequencing Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Targeted Sequencing And Resequencing Market, By Technology:
- Sequencing
- Re-sequencing
- Targeted Sequencing And Resequencing Market, By Type:
- DNA-based targeted sequencing
- RNA-based targeted sequencing
- Targeted Sequencing And Resequencing Market, By Application:
- Clinical application
- Plant and animal sciences
- Drug development
- Others
- Targeted Sequencing And Resequencing Market, By End - use:
- Hospitals & clinics
- Academic research
- Others
- Targeted Sequencing And Resequencing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Targeted Sequencing And Resequencing Market.
Available Customizations:
Global Targeted Sequencing And Resequencing market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Technology (Sequencing, Re-sequencing( Electrophoresis-based resequencing, NGS, Array-based resequencing))
4.2.2. By Type (DNA-based targeted sequencing, RNA-based targeted sequencing)
4.2.3. By Application (Clinical application, Plant and animal sciences, Drug development, Others)
4.2.4. By End use (Hospitals & clinics, Academic research, Others)
4.2.5. By Region
4.2.6. By Company (2023)
4.3. Market Map
4.3.1. By Technology
4.3.2. By Type
4.3.3. By Application
4.3.4. By End use
4.3.5. By Region
5. ASIA PACIFIC TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Type
5.2.3. By Application
5.2.4. By End use
5.2.5. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Targeted Sequencing And Resequencing Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Technology
5.3.1.2.2. By Type
5.3.1.2.3. By Application
5.3.1.2.4. By End use
5.3.2. India Targeted Sequencing And Resequencing Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Technology
5.3.2.2.2. By Type
5.3.2.2.3. By Application
5.3.2.2.4. By End use
5.3.3. Australia Targeted Sequencing And Resequencing Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Technology
5.3.3.2.2. By Type
5.3.3.2.3. By Application
5.3.3.2.4. By End use
5.3.4. Japan Targeted Sequencing And Resequencing Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Technology
5.3.4.2.2. By Type
5.3.4.2.3. By Application
5.3.4.2.4. By End use
5.3.5. South Korea Targeted Sequencing And Resequencing Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Technology
5.3.5.2.2. By Type
5.3.5.2.3. By Application
5.3.5.2.4. By End use
6. EUROPE TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Type
6.2.3. By Application
6.2.4. By End use
6.2.5. By Country
6.3. Europe: Country Analysis
6.3.1. France Targeted Sequencing And Resequencing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Type
6.3.1.2.3. By Application
6.3.1.2.4. By End use
6.3.2. Germany Targeted Sequencing And Resequencing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Type
6.3.2.2.3. By Application
6.3.2.2.4. By End use
6.3.3. Spain Targeted Sequencing And Resequencing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Type
6.3.3.2.3. By Application
6.3.3.2.4. By End use
6.3.4. Italy Targeted Sequencing And Resequencing Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Type
6.3.4.2.3. By Application
6.3.4.2.4. By End use
6.3.5. United Kingdom Targeted Sequencing And Resequencing Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Type
6.3.5.2.3. By Application
6.3.5.2.4. By End use
7. NORTH AMERICA TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Type
7.2.3. By Application
7.2.4. By End use
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Targeted Sequencing And Resequencing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Type
7.3.1.2.3. By Application
7.3.1.2.4. By End use
7.3.2. Mexico Targeted Sequencing And Resequencing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Type
7.3.2.2.3. By Application
7.3.2.2.4. By End use
7.3.3. Canada Targeted Sequencing And Resequencing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Type
7.3.3.2.3. By Application
7.3.3.2.4. By End use
8. SOUTH AMERICA TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Type
8.2.3. By Application
8.2.4. By End use
8.2.5. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Targeted Sequencing And Resequencing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Type
8.3.1.2.3. By Application
8.3.1.2.4. By End use
8.3.2. Argentina Targeted Sequencing And Resequencing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Type
8.3.2.2.3. By Application
8.3.2.2.4. By End use
8.3.3. Colombia Targeted Sequencing And Resequencing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Type
8.3.3.2.3. By Application
8.3.3.2.4. By End use
9. MIDDLE EAST AND AFRICA TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Type
9.2.3. By Application
9.2.4. By End use
9.2.5. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Targeted Sequencing And Resequencing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Type
9.3.1.2.3. By Application
9.3.1.2.4. By End use
9.3.2. Saudi Arabia Targeted Sequencing And Resequencing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Type
9.3.2.2.3. By Application
9.3.2.2.4. By End use
9.3.3. UAE Targeted Sequencing And Resequencing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Type
9.3.3.2.3. By Application
9.3.3.2.4. By End use
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: SWOT ANALYSIS
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. COMPETITIVE LANDSCAPE
14.1. Agilent Technologies Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Illumina, Inc.
14.3. F. Hoffmann-La Roche Ltd
14.4. Thermo Fisher Scientific, Inc.
14.5. DNASTAR Inc.
14.6. Bio-Rad Laboratories, Inc.
14.7. Integrated DNA Technologies, Inc.
14.8. Perkin Elmer, Inc.
14.9. RainDance Technologies, Inc.
14.10. Genomatix Gmbh
14.11. Macrogen, Inc.
14.12. GATC Biotech Ag
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Technology (Sequencing, Re-sequencing( Electrophoresis-based resequencing, NGS, Array-based resequencing))
4.2.2. By Type (DNA-based targeted sequencing, RNA-based targeted sequencing)
4.2.3. By Application (Clinical application, Plant and animal sciences, Drug development, Others)
4.2.4. By End use (Hospitals & clinics, Academic research, Others)
4.2.5. By Region
4.2.6. By Company (2023)
4.3. Market Map
4.3.1. By Technology
4.3.2. By Type
4.3.3. By Application
4.3.4. By End use
4.3.5. By Region
5. ASIA PACIFIC TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Type
5.2.3. By Application
5.2.4. By End use
5.2.5. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Targeted Sequencing And Resequencing Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Technology
5.3.1.2.2. By Type
5.3.1.2.3. By Application
5.3.1.2.4. By End use
5.3.2. India Targeted Sequencing And Resequencing Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Technology
5.3.2.2.2. By Type
5.3.2.2.3. By Application
5.3.2.2.4. By End use
5.3.3. Australia Targeted Sequencing And Resequencing Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Technology
5.3.3.2.2. By Type
5.3.3.2.3. By Application
5.3.3.2.4. By End use
5.3.4. Japan Targeted Sequencing And Resequencing Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Technology
5.3.4.2.2. By Type
5.3.4.2.3. By Application
5.3.4.2.4. By End use
5.3.5. South Korea Targeted Sequencing And Resequencing Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Technology
5.3.5.2.2. By Type
5.3.5.2.3. By Application
5.3.5.2.4. By End use
6. EUROPE TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Type
6.2.3. By Application
6.2.4. By End use
6.2.5. By Country
6.3. Europe: Country Analysis
6.3.1. France Targeted Sequencing And Resequencing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Type
6.3.1.2.3. By Application
6.3.1.2.4. By End use
6.3.2. Germany Targeted Sequencing And Resequencing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Type
6.3.2.2.3. By Application
6.3.2.2.4. By End use
6.3.3. Spain Targeted Sequencing And Resequencing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Type
6.3.3.2.3. By Application
6.3.3.2.4. By End use
6.3.4. Italy Targeted Sequencing And Resequencing Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Type
6.3.4.2.3. By Application
6.3.4.2.4. By End use
6.3.5. United Kingdom Targeted Sequencing And Resequencing Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Type
6.3.5.2.3. By Application
6.3.5.2.4. By End use
7. NORTH AMERICA TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Type
7.2.3. By Application
7.2.4. By End use
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Targeted Sequencing And Resequencing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Type
7.3.1.2.3. By Application
7.3.1.2.4. By End use
7.3.2. Mexico Targeted Sequencing And Resequencing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Type
7.3.2.2.3. By Application
7.3.2.2.4. By End use
7.3.3. Canada Targeted Sequencing And Resequencing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Type
7.3.3.2.3. By Application
7.3.3.2.4. By End use
8. SOUTH AMERICA TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Type
8.2.3. By Application
8.2.4. By End use
8.2.5. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Targeted Sequencing And Resequencing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Type
8.3.1.2.3. By Application
8.3.1.2.4. By End use
8.3.2. Argentina Targeted Sequencing And Resequencing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Type
8.3.2.2.3. By Application
8.3.2.2.4. By End use
8.3.3. Colombia Targeted Sequencing And Resequencing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Type
8.3.3.2.3. By Application
8.3.3.2.4. By End use
9. MIDDLE EAST AND AFRICA TARGETED SEQUENCING AND RESEQUENCING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Type
9.2.3. By Application
9.2.4. By End use
9.2.5. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Targeted Sequencing And Resequencing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Type
9.3.1.2.3. By Application
9.3.1.2.4. By End use
9.3.2. Saudi Arabia Targeted Sequencing And Resequencing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Type
9.3.2.2.3. By Application
9.3.2.2.4. By End use
9.3.3. UAE Targeted Sequencing And Resequencing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Type
9.3.3.2.3. By Application
9.3.3.2.4. By End use
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: SWOT ANALYSIS
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. COMPETITIVE LANDSCAPE
14.1. Agilent Technologies Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Illumina, Inc.
14.3. F. Hoffmann-La Roche Ltd
14.4. Thermo Fisher Scientific, Inc.
14.5. DNASTAR Inc.
14.6. Bio-Rad Laboratories, Inc.
14.7. Integrated DNA Technologies, Inc.
14.8. Perkin Elmer, Inc.
14.9. RainDance Technologies, Inc.
14.10. Genomatix Gmbh
14.11. Macrogen, Inc.
14.12. GATC Biotech Ag
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
